15. Warrants (Details) (Warrant, USD $)
|
12 Months Ended | |
---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
Warrant
|
||
Warrant | ||
Number of Warrants outstanding beginning balance |
0us-gaap_ClassOfWarrantOrRightOutstanding / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
|
Warrants Granted |
300,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
|
Warrants Exercised |
0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
|
Warrants Expired |
0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
|
Number of Warrants outstanding ending balance |
300,000us-gaap_ClassOfWarrantOrRightOutstanding / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
|
Number of Warrants exercisable |
300,000GNUS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
0GNUS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
Exercise Price Per Share | ||
Exericse price per share, granted |
$ 2.00us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
|
Exercise price per share, ending balance |
$ 2.00us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
|
Exercise price per share, exercisable |
$ 2.00GNUS_WarrantExercisePricePerShareExercisable / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
$ 0GNUS_WarrantExercisePricePerShareExercisable / us-gaap_AwardTypeAxis = us-gaap_WarrantMember |
Weighted average remaining contractual life, warrants granted | 4 years 4 months 13 days | |
Weighted average remaining contractual life | 4 years 4 months 13 days | |
Weighted average remaining contractual life, exercisable | 4 years 4 months 13 days |
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Number of Warrants exercisable No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|